Ctrl

K

Dalfampridine ER

Class
Potassium channel blockers
Subclass
Potassium channel blockers
Generic name
Dalfampridine, 4-Aminopyridine, 4-AC, fampridine ER
Brand names
Ampyra®
Common formulations
Tablet
Dosage and administration
Adults patients
Treatment of multiple sclerosis
•
10 mg PO BID
Indications for use
Labeled indications
Adults
•
Treatment of multiple sclerosis
Pregnancy and breastfeeding
Breastfeeding
Little information available on breastfeeding safety.
Unknown amount excreted in breastmilk.
Unknown drug levels in breastfed infants.
Adverse reactions
Very common > 10%
•
Nausea, vomiting, urinary tract infections
Common 1-10%
•
Multiple sclerosis, nasopharyngitis, abdominal pain, anxiety, asthenia, back pain, constipation, dizziness, gait disturbance, headache, indigestion, insomnia, paresthesia, throat pain
Unknown frequency
•
Anaphylaxis, angioedema, dyspnea, seizure, urticaria
Interactions
Drug(s)
Check Interactions
Reset

What did you think about this content?

Create free account

Sign up for free to access the full drug resource